Santiago M J, Gómez C, Magaña I, Muñoz V, Saiz P, Sánchez A, López-Herce J
Servicio de Cuidados Intensivos Pediátricos, Hospital General Universitario Gregorio Marañón, Madrid, España; Instituto de Investigación Sanitaria, Hospital Gregorio Marañón, Madrid, España; Red de Salud Maternoinfantil y del Desarrollo (Red SAMID) RD16/0022/0007, Madrid RETICS financiada por el PN I+D+I 2008-2011, ISCIII, Subdirección General de Evaluación y Fomento de la Investigación y el Fondo Europeo de Desarrollo Regional (FEDER), ef. RD16/0022/0007.
Departamento de Pediatría, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España.
Med Intensiva (Engl Ed). 2019 Jun-Jul;43(5):281-289. doi: 10.1016/j.medin.2018.02.003. Epub 2018 Mar 29.
To analyze the hematological complications and need for transfusions in children receiving extracorporeal life support (ECLS).
A retrospective study was carried out.
A pediatric intensive care unit.
Children under 18 years of age subjected to ECLS between September 2006 and November 2015.
None.
Patient and ECLS characteristics, anticoagulation, hematological and coagulation parameters, transfusions and clinical course.
A total of 100 patients (94 with heart disease) with a median age of 11 months were studied. Seventy-six patients presented bleeding. The most frequent bleeding point was the mediastinum and 39 patients required revision surgery. In the first 3days, 97% of the patients required blood transfusion (34.4ml/kg per day), 94% platelets (21.1ml/kg per day) and 90% plasma (26.6ml/kg per day). Patients who were in the postoperative period, those who were bleeding at the start of ECLS, those requiring revision surgery, those who could not suspend extracorporeal circulation, and those subjected to transthoracic cannulation required a greater volume of transfusions than the rest of the patients. Thromboembolism occurred in 14 patients and hemolysis in 33 patients. Mortality among the children who were bleeding at the start of ECLS (57.6%) was significantly higher than in the rest of the patients (37.5%) (P=.048).
Children subjected to ECLS present high blood product needs. The main factors related to transfusions were the postoperative period, bleeding at the start of ECLS, revision surgery, transthoracic cannulation, and the impossibility of suspending extracorporeal circulation. Children with bleeding suffered greater mortality than the rest of the patients.
分析接受体外生命支持(ECLS)的儿童的血液学并发症及输血需求。
进行一项回顾性研究。
儿科重症监护病房。
2006年9月至2015年11月期间接受ECLS的18岁以下儿童。
无。
患者和ECLS特征、抗凝、血液学和凝血参数、输血及临床病程。
共研究了100例患者(94例患有心脏病),中位年龄为11个月。76例患者出现出血。最常见的出血部位是纵隔,39例患者需要进行修复手术。在最初3天,97%的患者需要输血(每天34.4ml/kg),94%需要输注血小板(每天21.1ml/kg),90%需要输注血浆(每天26.6ml/kg)。处于术后阶段的患者、在ECLS开始时出血的患者、需要进行修复手术的患者、无法停止体外循环的患者以及接受经胸插管的患者比其他患者需要更多的输血量。14例患者发生血栓栓塞,33例患者发生溶血。在ECLS开始时出血的儿童的死亡率(57.6%)显著高于其他患者(37.5%)(P = 0.048)。
接受ECLS的儿童对血液制品的需求很高。与输血相关的主要因素是术后阶段、ECLS开始时出血、修复手术、经胸插管以及无法停止体外循环。出血的儿童比其他患者的死亡率更高。